Keyphrases
Acute Myeloid Leukemia
89%
Triple-negative Breast Cancer
48%
Venetoclax
48%
Ganglioside GD2
40%
FMS-like Tyrosine Kinase 3 (FLT3)
36%
Epithelial-mesenchymal Transition
36%
Breast
32%
Cancer Stem-like
32%
Acute Myeloid Leukemia Cells
29%
Acquired Resistance
29%
Myeloid Cell leukemia-1 (Mcl-1)
29%
Leukemia
27%
Tumor Growth
26%
Bcl-2 Inhibitor
25%
Tumor
24%
Mesenchymal Stromal Cells
24%
Inhibitor Resistance
24%
Mesenchymal Stem Cells
24%
RAS-MAPK Pathway
24%
GD3 Synthase
22%
Metastasis
18%
ST8SIA1
18%
Signaling Pathway
17%
AML Cells
17%
Natural Killer
16%
Epithelial-to-mesenchymal Transition
16%
Chemotherapy
14%
FOXC2
14%
Natural Killer Cells
14%
Tumor Metastasis
14%
Novel Therapeutic Targets
14%
Targeted Therapy
13%
Dual Inhibitor
13%
Microenvironment
13%
CD24
13%
Stem Cells
13%
Co-target
12%
Therapeutic Strategies
12%
Solid Tumors
12%
Bioluminescence Imaging
12%
Osteogenic Differentiation
12%
FLT3 Inhibitor
12%
CD271
12%
Oncotarget
12%
Interleukin-8
12%
Tumor Progression
12%
Improved Outcomes
12%
Cell Tropism
12%
Bruton's Tyrosine Kinase
12%
FMS-like Tyrosine Kinase 3 Internal Tandem Duplication
12%
Medicine and Dentistry
Acute Myeloid Leukemia
98%
Leukemia
49%
Leukemia Cell
45%
Mesenchymal Stem Cell
44%
Venetoclax
37%
Triple Negative Breast Cancer
36%
Breast Cancer
35%
Connective Tissue Growth Factor
27%
Mesenchymal-Epithelial Transition
26%
extracellular signal regulated kinase
25%
Metastatic Carcinoma
22%
Stem Cell
17%
Stromal Cell
17%
Receptor
17%
Tumor Progression
14%
Leukemogenesis
14%
Ganglioside GD2
14%
Myeloid Leukemia
14%
Targeted Therapy
13%
Engraftment
13%
Breast Tumor
13%
Acute Lymphoblastic Leukemia
13%
Natural Killer Cell
12%
Adipocyte
12%
Bruton Tyrosine Kinase
12%
FMS-Like Tyrosine Kinase 3
12%
Hematopoietic Cell
12%
Aldehyde Dehydrogenase
12%
Synthetase
12%
Activin A
12%
Signal Transduction
12%
Stage Specific Embryo Antigen 4
12%
Dinutuximab
12%
Monoclonal Antibody
12%
Hematopoiesis
12%
Autophagy
12%
Therapy Resistance
12%
Astrocyte
12%
Phosphoprotein
12%
Bone Marrow Stromal Cell
12%
Interleukin 8
12%
Cell Killing
12%
Induced Pluripotent Stem Cell
12%
Bone Marrow Microenvironment
10%
Quizartinib
8%
Programmed Cell Death
8%
Neoplasm
7%
Cell Signaling Pathway
7%
Diseases
7%
Stroma
6%
Biochemistry, Genetics and Molecular Biology
GD2
100%
Stromal Cell
74%
Ganglioside
66%
Myeloid
65%
Synthase
45%
Stem Cell
41%
Mesenchymal-Epithelial Transition
40%
Cancer Stem Cell
40%
Carcinogenesis
33%
Connective Tissue Growth Factor
27%
Tumor Progression
26%
Monoclonal Antibody
25%
Lipid Metabolism
24%
Cancer Cell
18%
Adipocyte
13%
Hematopoietic Cell
13%
Drug Resistance
13%
Aldehyde Dehydrogenase
12%
2,5-Dimethoxy-4-iodoamphetamine
12%
B7 (Protein)
12%
Hematopoiesis
12%
Complement Factor B
12%
VCAM-1
12%
Interleukin 8
12%
Natural Killer Cell Mediated Cytotoxicity
12%
Astrocyte
12%
Frizzled
12%
Phosphoprotein
12%
ALDH2
12%
Activin
12%
Immune Checkpoints
12%
Enzyme
11%
Anabolism
10%
CD44
9%
Cell Function
8%
CD24
7%
Stem Cell Marker
7%
Gene Expression Profiling
6%
Mouse Model
6%
Protein Expression
5%
P53
5%